ビガバトリンと行動障害

Same author

African leadership in brain diplomacy: The Yaoundé declaration advances the global brain economy playbook for better brain health.

Neuroscience·2025

Same author

High prevalence of epilepsy in Southern and Northern Rwanda: Myth or reality?

Tropical medicine & international health : TM & IH·2024

Same author

Late-life terminal seizure freedom in drug-resistant epilepsy: "Burned-out epilepsy".

Journal of the neurological sciences·2021

Same author

The impact of COVID-19 on epilepsy care: Perspectives from UK healthcare workers.

Epilepsy & behavior reports·2021

Same author

Comparing two classification schemes for seizures and epilepsy in rural China.

European journal of neurology·2018

Same author

Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

European journal of neurology·2018

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

ビガバトリンと行動障害

関連する概念動画

African leadership in brain diplomacy: The Yaoundé declaration advances the global brain economy playbook for better brain health.

High prevalence of epilepsy in Southern and Northern Rwanda: Myth or reality?

Late-life terminal seizure freedom in drug-resistant epilepsy: "Burned-out epilepsy".

The impact of COVID-19 on epilepsy care: Perspectives from UK healthcare workers.

Comparing two classification schemes for seizures and epilepsy in rural China.

Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

ビガバトリンと行動障害

関連する概念動画

関連記事

African leadership in brain diplomacy: The Yaoundé declaration advances the global brain economy playbook for better brain health.

High prevalence of epilepsy in Southern and Northern Rwanda: Myth or reality?

Late-life terminal seizure freedom in drug-resistant epilepsy: "Burned-out epilepsy".

The impact of COVID-19 on epilepsy care: Perspectives from UK healthcare workers.

Comparing two classification schemes for seizures and epilepsy in rural China.

Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.